Determining the Cause and Severity of Sepsis with a Point-of-Care Test
Sepsis remains one of medicine’s most intractable and costly problems, arising when an infection triggers a runaway immune response that damages organ...
Separating Signal from Noise in Regenerative Therapies
Rion is developing platelet-derived exosome therapeutics as off-the-shelf, room-temperature-stable alternatives to traditional cell therapies. The com...
Rewriting Drug Discovery with an AI-Multi-Omics Approach
The genomics revolution promised to unravel diseases and lead to treatments that addressed their root causes. In reality, says Mo Jain, your zip code ...
Overcoming Chemoresistance and Activating the Immune System in Difficult-to-Treat Cancers
The enzyme GSK3β, in healthy cells, is involved in glucose metabolism. In cancer cells, though, it serves as a master regulator of tumor growth, progr...
A Hub-and-Spoke Ophthalmology Company with an Eye for Innovation
Hub-and-spoke business models—the use of a central core of business functions with pipeline assets spun out into subsidiary companies—have gained trac...
An AI Collaborative that Welcomes All into the Fold
OpenFold, an open-source, collaborative initiative founded in 2022 to address the challenges of protein structure prediction and design using artifici...
Hitting the Reset Button on Cellular Aging
Transcription factors control the genetic programs that maintain cellular balance, but while they have been seen as compelling targets for aging-relat...
Changing the Ovarian Cancer Treatment Landscape with a DNA-Mediated Immunotherapy
Ovarian cancer remains one of the deadliest cancers affecting women, and it is expected to claim nearly 13,000 lives in the United States in 2025. Des...
Why the United States Must Fall in Love with Biotechnology, or Take a Back Seat to China
China’s emergence as a biotech superpower may have appeared to happen suddenly, but it reflected a long-term vision and policies over many years that ...
Transforming Drug Discovery and Disease Research—One Cell at a Time
The ARC Virtual Cell Atlas uses high-throughput single-cell genomics, artificial intelligence, and open science to understand the complexities of cell...